SAN FRANCISCO--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) today announced preliminary voting
results from its Annual Meeting of Stockholders, held earlier today in
Irving, Texas. All directors were re-elected, the non-binding advisory
vote on executive compensation was approved, and all Board vote
recommendations were supported.
“On behalf of our Board and management team, we appreciate the continued
support of our shareholders,” said John H. Hammergren, chairman and
chief executive officer, McKesson Corporation. “We greatly value our
shareholders’ perspective and we are committed to actively engaging with
them as we work to deliver long-term value for customers and investors.”
The shareholder vote announced today is considered preliminary until the
final results are tabulated and certified by the independent inspector
of election. The final results will be reported on a Form 8-K that will
be filed with the Securities and Exchange Commission shortly.
About McKesson Corporation
McKesson Corporation, currently ranked 6th on the FORTUNE
500, is a global leader in healthcare supply chain management solutions,
retail pharmacy, community oncology and specialty care, and healthcare
information technology. McKesson partners with pharmaceutical
manufacturers, providers, pharmacies, governments and other
organizations in healthcare to help provide the right medicines, medical
products and healthcare services to the right patients at the right
time, safely and cost-effectively. United by our ICARE shared
principles, our employees work every day to innovate and deliver
opportunities that make our customers and partners more successful — all
for the better health of patients. McKesson has been named the “Most
Admired Company” in the healthcare wholesaler category by FORTUNE, a
“Best
Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly
company by Military Friendly. For more information, visit www.mckesson.com.
